0001179110-18-002637.txt : 20180222 0001179110-18-002637.hdr.sgml : 20180222 20180222183940 ACCESSION NUMBER: 0001179110-18-002637 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180222 FILED AS OF DATE: 20180222 DATE AS OF CHANGE: 20180222 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HIRSCHHORN MARK CENTRAL INDEX KEY: 0001081343 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37477 FILM NUMBER: 18634088 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Teladoc, Inc. CENTRAL INDEX KEY: 0001477449 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011] IRS NUMBER: 043705970 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2 MANHATTANVILLE ROAD STREET 2: SUITE 203 CITY: PURCHASE STATE: NY ZIP: 10577 BUSINESS PHONE: 2036352002 MAIL ADDRESS: STREET 1: 2 MANHATTANVILLE ROAD STREET 2: SUITE 203 CITY: PURCHASE STATE: NY ZIP: 10577 4 1 edgar.xml FORM 4 - X0306 4 2018-02-22 0 0001477449 Teladoc, Inc. TDOC 0001081343 HIRSCHHORN MARK C/O TELADOC, INC., 2 MANHATTANVILLE ROAD, SUITE 203 PURCHASE NY 10577 0 1 0 0 Executive VP, COO and CFO Common Stock 2018-02-22 4 M 0 1002 1.67 A 65989 D Common Stock 2018-02-22 4 M 0 684 6.01 A 66673 D Common Stock 2018-02-22 4 M 0 31285 6.01 A 97958 D Employee Stock Option (right to buy) 1.67 2018-02-22 4 M 0 1002 0.00 D 2023-12-11 Common Stock 1002 17024 D Employee Stock Option (right to buy) 6.01 2018-02-22 4 M 0 684 0.00 D 2024-09-10 Common Stock 684 12986 D Employee Stock Option (right to buy) 6.01 2018-02-22 4 M 0 31285 0.00 D 2024-12-22 Common Stock 31285 50249 D The option vested as to 25% of the shares on December 11, 2014. The remainder of the shares vest in 36 equal monthly installments thereafter. The option vested as to 25% of the shares on September 10, 2015. The remainder of the shares vest in 36 equal monthly installments thereafter. The option vested as to 25% of the shares on December 22, 2015. The remainder of the shares vest in 36 equal monthly installments thereafter. /s/ Adam C. Vandervoort, attorney-in-fact 2018-02-22